History and Possible Uses of Nanomedicine Based on Nanoparticles and Nanotechnological Progress

Abstract

Nanomedicine is a key science of the 21 st century. Although the production and use of nanosized particles had taken place in several ways in ancient times and hundreds of years ago, nanomedicine as a modern interdisciplinary science was first established in the nineties of the last century only. The basis of this new science derives from the development of an array of ultramicroscopic devices and the studies of cellular, molecular and finally atomsized structures in biology, chemistry and physics in the 20 th century. The nanotechnological approach, first framed in the 1950's by Richard P. Feynman, was the constitutive force to establish nanomedicine as a paramount section in science and medical treatments. From the beginning nanomedicine developed rapidly, driven by tremendous progress in techniques. Its historical evolvement and diversification into a wide range of medical applications (e.g. tissue engineering) and its increasing relevance for a large bunch of disease categories are outlined. Essential application and/or research areas comprise the use of biosensors for diagnostic reasons (including nanoimaging and lab-on-the-chip) and biocompatible nanomaterials (such as liposomes) as drug, vaccine and gene vehicles for therapy, most prominently as nanocapsules for cancer treatment (in connection to hyperthermia, thermoablation and radiotherapy methods where appropriate). Future directions remain multi-fold, the most important ones defined as drug delivery, theranostics, tissue engineering, and magnetofection. Some novel developments (regarding cancer treatment and stent angioplasty) are presented. Regenerative medicine and gene therapy are of rising importance

A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles

“…From the very few nanotechnologies born in the 1970's early 1980s', the field has expanded tremendously and became a separate field of nanotechnologies dedicated to health care named nanomedicine in the 1990s' [see Krukemeyer et al, 2015]. From the simple idea of improving drug delivery to target sites has emerged an area in which the use of nanotechnology is being currently considered in a much wider range of applications, including the combination of treatment and diagnosis with high promise for the development of personalized medicine [Mura and Couvreur, 2012, Ryu et al, 2014, Fornaguera and Garcia-Celma, 2017.…”

Advances on the formulation of proteins using nanotechnologies

“…A C C E P T E D ACCEPTED MANUSCRIPT 4 The possibility of including peptides and proteins in nanovehicles that are able to protect and deliver them at the adequate site has generated increasing expectation during last decades ( Fig. 1) [5]. Liposomes were the first nanocarriers proposed for protein delivery in the early 70's [6,7].…”

Liposomal Drug Delivery to the Central Nervous System

“…In spite of the countless studies, the effective and safe inhibition of the P-gp at the human BBB is not yet a reality. A non-invasive strategy that takes advantage of the CNS physiology involves nanomedicine [41]. This innovative strategy uses mainly nano-scale drug delivery systems (DDSs) such as liposomes, polymeric nanoparticles, lipid nanocapsules, and polymersomes.…”